Real-time enrollment status for this bipolar disorder clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:37 AM UTC
| NCT Number | NCT06929273 |
| Recruiting Status | Recruiting |
| Condition | Bipolar Disorder |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 52 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | July 15, 2026 (3 days ago) |
As of July 18, 2026: Clinical trial NCT06929273 is currently recruiting participants. This phase3 study for bipolar disorder is actively seeking new participants at 52 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06929273 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06929273 was last updated 3 days ago (July 15, 2026). HelloStudys verifies this status automatically.